TrialOncoimmunology2021

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.

Kaifeng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.